FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order

Written By Anthony Pizzarelli

https://www.fda.gov/news-events/press-announcements/fda-accelerates-action-treatments-serious-mental-illness-following-executive-order

Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders

Anthony Pizzarelli
Previous

Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes
Next

Psilocybin, in 10mg or 25mg doses, has no short- or long-term detrimental effects in healthy people. Link: